Blaabjerg O, Hyltoft Petersen P, Dreyer T, Hørder M, Haas V, Jørgensen P J
Scand J Clin Lab Invest Suppl. 1984;172:79-86.
In this subproject a method for S-triiodothyronine was used for evaluation of the specified system of internal quality control. Decisions on acceptance and rejection of series were based on results from a human pool with triiodothyronine concentration at the upper reference limit. In the parallel system specimens from patients and from healthy individuals were used in combination with artificial materials so that changes in accuracy, specificity, and detectability could be disclosed. The results were examined for false rejections and false acceptances. For all the seven rejections in 117 series due to a mean rule of 8 controls with a pfr of 0.01, the parallel system supported the decisions. In eight occasions the series were rejected due to a range rule with a pfr of 0.05; one rejection was confirmed by the parallel system and the remaining seven times out of the 117 series were close to the expected five percent of false rejections. A small systematic change in standardization of about eight percent was too small to be recognized by the quality control system. The specificity was not changed during the investigation period; all of the systematic changes were caused by variations in the standard materials. In conclusion the investigation confirmed the validity of the specified system of internal quality control.
在这个子项目中,采用了一种测定三碘甲状腺原氨酸的方法来评估特定的内部质量控制系统。系列结果的接受和拒绝决策基于来自三碘甲状腺原氨酸浓度处于参考上限的混合人血清样本的结果。在平行系统中,将患者和健康个体的样本与人工材料结合使用,以便揭示准确性、特异性和可检测性的变化。对结果进行了假拒绝和假接受检查。对于117个系列中因8个对照的均值规则(假拒绝率为0.01)导致的所有7次拒绝,平行系统支持这些决策。有8次系列结果因范围规则(假拒绝率为0.05)被拒绝;其中1次拒绝得到平行系统的确认,在117个系列中的其余7次接近预期的5%假拒绝率。约8%的标准化方面的微小系统变化太小,质量控制系统无法识别。在调查期间特异性没有改变;所有系统变化都是由标准物质的差异引起的。总之,该调查证实了特定内部质量控制系统的有效性。